Immediate Impact
2 by Nobel laureates 3 from Science/Nature 59 standout
Citing Papers
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Dual-Site Biomimetic Cu/Zn-MOF for Atopic Dermatitis Catalytic Therapy via Suppressing FcγR-Mediated Phagocytosis
2024 Standout
Works of Mark D. P. Davis being referenced
Squamous Cell Carcinoma in Perineal, Perianal, and Gluteal Hidradenitis Suppurativa: Experience in 12 Patients
2019
Pediatric Hospital Dermatology: Experience with Inpatient and Consult Services at the Mayo Clinic
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Mark D. P. Davis | 693 | 481 | 549 | 84 | 2.2k | |
| Robert G. Micheletti | 857 | 723 | 365 | 98 | 2.1k | |
| Alexandra Balbir‐Gurman | 392 | 449 | 903 | 116 | 2.5k | |
| Fernanda Falcini | 181 | 206 | 703 | 61 | 2.3k | |
| Hossein C. Nousari | 399 | 588 | 1070 | 73 | 2.6k | |
| Stanley M. Naguwa | 175 | 220 | 1022 | 42 | 2.1k | |
| Eun Ha Kang | 114 | 658 | 1070 | 123 | 2.5k | |
| Roberta Gualtierotti | 309 | 191 | 590 | 102 | 2.4k | |
| K.H. Ly | 453 | 389 | 1179 | 138 | 2.6k | |
| Yolanda Braun‐Moscovici | 152 | 285 | 489 | 78 | 1.5k | |
| Michael David | 754 | 278 | 291 | 66 | 1.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...